What is the appropriate evaluation and management for a 36-year-old adult presenting with a cardiac arrhythmia?

Evaluation and Management of Cardiac Arrhythmia in a 36-Year-Old

For a 36-year-old presenting with cardiac arrhythmia, immediate assessment of hemodynamic stability is paramount—if unstable (systolic BP ≤90 mmHg, chest pain, heart failure, altered consciousness), proceed directly to synchronized cardioversion; if stable, obtain a 12-lead ECG immediately to differentiate narrow-complex from wide-complex tachycardia and guide specific treatment. 1, 2

Initial Assessment Algorithm

Step 1: Determine Hemodynamic Stability

Assess immediately for:

• Systolic blood pressure ≤90 mmHg
• Chest pain or signs of myocardial ischemia
• Heart failure symptoms (dyspnea, pulmonary edema)
• Altered level of consciousness
• Heart rate ≥150 bpm with symptoms 3, 1

If ANY of these are present → Patient is UNSTABLE → Proceed to synchronized cardioversion 2

Step 2: Obtain 12-Lead ECG

This is the gold standard for diagnosis and must be performed immediately 4, 5. The ECG will determine:

• Narrow-complex (<120 ms) vs. wide-complex (≥120 ms) tachycardia
• Regular vs. irregular rhythm
• Presence of pre-excitation (delta waves suggesting WPW)

Management Based on Rhythm Type

For STABLE Narrow-Complex Regular Tachycardia (Most Likely SVT/AVNRT)

First-line: Vagal maneuvers 2

• Modified Valsalva maneuver: Patient supine, bear down against closed glottis for 10-30 seconds (equivalent to 30-40 mmHg intrathoracic pressure)
• Carotid sinus massage: Apply steady pressure over carotid sinus for 5-10 seconds after confirming absence of bruit
• Ice-cold wet towel to face (diving reflex)
• Success rate approximately 28% 2

Second-line: Adenosine 2

• 6 mg rapid IV push followed by 20 mL saline flush
• If no effect after 1-2 minutes: 12 mg IV push
• Can repeat 12 mg once more if needed
• Terminates AVNRT in ~95% of cases 2
• Critical caveat: Have defibrillator ready—can precipitate atrial fibrillation, especially dangerous in WPW patients 1
• Contraindicated in asthma (causes bronchospasm) 3
• Reduce dose in cardiac transplant patients or those on dipyridamole/carbamazepine 1

Third-line: IV beta-blockers, diltiazem, or verapamil 2

• Metoprolol or other IV beta-blocker (Class IIa recommendation)
• Diltiazem or verapamil 5-10 mg IV over 60 seconds 3
• Effective in 30-50% for termination or rate control 2
• Never combine verapamil with beta-blockers (risk of profound bradycardia/hypotension) 3
• Monitor closely for hypotension and bradycardia 2

For STABLE Wide-Complex Tachycardia (Assume VT Until Proven Otherwise)

In a 36-year-old, consider both VT and SVT with aberrancy, but treat as VT if uncertain 3

First-line pharmacologic: Lidocaine (Lignocaine) 3

• 50 mg IV over 2 minutes, repeat every 5 minutes to total 200 mg
• If successful: maintain with 2-4 mg/min infusion
• No effect on SVT, so diagnostic as well as therapeutic 3

Alternative: Amiodarone 3

• 150 mg IV bolus for stable VT
• Then 1 mg/min × 6 hours, then 0.5 mg/min × 18 hours
• Can be used for both ventricular and supraventricular arrhythmias 3
• Antiarrhythmic effect may take up to 30 minutes 3

If medications fail or patient deteriorates: Synchronized cardioversion 3

• 100 J → 200 J → 360 J (or biphasic equivalent)

For UNSTABLE Patients (Any Rhythm)

Immediate synchronized cardioversion 2, 6

• Do NOT delay for pharmacologic therapy
• Sedate if time permits
• For atrial flutter/SVT: can start with lower energies (50-100 J biphasic) 6
• For VT: 100 J → 200 J → 360 J 3

Essential Diagnostic Workup

Immediate (in all patients):

• 12-lead ECG 4, 5
• Electrolytes (especially potassium, magnesium—correct abnormalities immediately)
• Thyroid function tests (hyperthyroidism common trigger)
• Troponin (if chest pain or concern for ischemia)

Subsequent evaluation (stable patients):

• Echocardiography to evaluate for structural heart disease 4, 5
• Ambulatory ECG monitoring (24-48 hour Holter or event monitor) if diagnosis unclear 4, 5
• Exercise stress testing if exercise-induced symptoms 4
• Consider electrophysiology study if recurrent symptoms or high-risk features 4

Critical Pitfalls to Avoid

1. Never give verapamil or diltiazem for wide-complex tachycardia—can cause cardiovascular collapse if VT 3
2. Never combine beta-blockers with verapamil/diltiazem—risk of severe bradycardia 3
3. Adenosine in WPW with atrial fibrillation can be fatal—can accelerate ventricular rate via accessory pathway 1
4. Don't assume wide-complex = VT in young patients—but always treat as VT if uncertain 3
5. Correct hypoxia, electrolytes, and underlying triggers before assuming primary arrhythmia 6

Age-Specific Considerations for 36-Year-Old

At age 36, consider:

• Congenital heart disease (especially if history of repair) 4
• Cardiomyopathies (hypertrophic, dilated, ARVC)
• Genetic arrhythmia syndromes (Long QT, Brugada, CPVT)
• WPW syndrome (accessory pathway-mediated tachycardia)
• Substance use (cocaine, amphetamines, excessive caffeine/alcohol)
• Structural heart disease less likely than older patients, but must exclude 4

Follow-Up and Long-Term Management

After acute stabilization:

• Cardiology referral for all patients with documented arrhythmia 4
• Electrophysiology referral for consideration of catheter ablation, especially for recurrent AVNRT/AVRT (curative in >95%) 2, 7
• Genetic testing if family history of sudden death or suspected inherited arrhythmia syndrome 4
• Risk stratification for sudden cardiac death based on underlying substrate 6

The key distinction in this age group is that catheter ablation offers definitive cure for most SVTs with minimal risk, making it preferable to chronic antiarrhythmic therapy in symptomatic patients. 7